Geode Capital Management, LLC Avrobio, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.15 - $1.48 $6,811 - $8,766	5,923 Added 1.62%	372,439 $476,000
Q4 2023 Feb 13, 2024	BUY	$1.22 - $1.62 $16,348 - $21,708	13,400 Added 3.79%	366,516 $498,000
Q3 2023 Nov 13, 2023	BUY	$0.98 - $1.62 $9,187 - $15,187	9,375 Added 2.73%	353,116 $543,000
Q2 2023 Aug 11, 2023	BUY	$0.58 - $1.31 $7,672 - $17,329	13,229 Added 4.0%	343,741 $326,000
Q1 2023 May 15, 2023	SELL	$0.76 - $1.82 $42,106 - $100,833	-55,403 Reduced 14.36%	330,512 $330,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $0.91 $603 - $858	-943 Reduced 0.24%	385,915 $275,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $269,117 - $477,234	-358,823 Reduced 48.12%	386,858 $355,000
Q1 2022 May 13, 2022	BUY	$1.29 - $4.04 $123,161 - $385,714	95,474 Added 14.68%	745,681 $984,000
Q4 2021 Feb 11, 2022	BUY	$3.45 - $6.05 $252,964 - $443,604	73,323 Added 12.71%	650,207 $2.5 Million
Q3 2021 Nov 12, 2021	SELL	$5.53 - $9.28 $248,733 - $417,405	-44,979 Reduced 7.23%	576,884 $3.22 Million
Q2 2021 Aug 13, 2021	BUY	$7.84 - $12.6 $205,000 - $329,464	26,148 Added 4.39%	621,863 $5.53 Million
Q1 2021 May 12, 2021	BUY	$10.54 - $19.3 $936,099 - $1.71 Million	88,814 Added 17.52%	595,715 $7.56 Million
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $1.03 Million - $1.37 Million	80,234 Added 18.8%	506,901 $7.07 Million
Q3 2020 Nov 13, 2020	BUY	$12.99 - $19.41 $135,654 - $202,698	10,443 Added 2.51%	426,667 $5.56 Million
Q2 2020 Aug 13, 2020	BUY	$12.19 - $22.96 $720,099 - $1.36 Million	59,073 Added 16.54%	416,224 $7.26 Million
Q1 2020 May 14, 2020	BUY	$10.08 - $27.21 $616,543 - $1.66 Million	61,165 Added 20.66%	357,151 $5.56 Million
Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $227,774 - $381,893	17,454 Added 6.27%	295,986 $5.96 Million
Q3 2019 Nov 12, 2019	BUY	$14.12 - $23.44 $1.85 Million - $3.08 Million	131,357 Added 89.25%	278,532 $3.93 Million
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $302,905 - $625,759	22,930 Added 18.46%	147,175 $2.39 Million
Q1 2019 May 14, 2019	BUY	$12.46 - $22.05 $473,828 - $838,517	38,028 Added 44.11%	124,245 $2.74 Million
Q4 2018 Feb 13, 2019	BUY	$15.43 - $32.7 $320,079 - $678,328	20,744 Added 31.68%	86,217 $1.44 Million
Q3 2018 Nov 13, 2018	BUY	$26.95 - $52.7 $1.76 Million - $3.45 Million	65,473 New	65,473 $3.4 Million

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account